DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Albaconazole is an investigational drug.
There have been 6 clinical trials for Albaconazole. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2011.
The most common disease conditions in clinical trials are Onychomycosis, Tinea Pedis, and Tinea. The leading clinical trial sponsors are Stiefel, a GSK Company, GlaxoSmithKline, and Drugs for Neglected Diseases.
Recent Clinical Trials for Albaconazole
|Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas Disease||Eisai Co., Ltd.||Phase 2|
|Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas Disease||Drugs for Neglected Diseases||Phase 2|
|A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule||GlaxoSmithKline||Phase 1|